(Q85648282)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

L Naditch-Brule

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

C Farsang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

W Zidek

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

13 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

412-416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23235366%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jhh.2012.61

20 February 2020

exact match

0 references

cites work

Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Heart rate and cardiovascular mortality: the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Heart rate: a strong predictor of mortality in subjects with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Pulse pressure reduction and cardiovascular protection.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Metabolic syndrome and age-related progression of aortic stiffness

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Blood pressure control in Italy: results of recent surveys on hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Hypertension treatment and control in five European countries, Canada, and the United States

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Blood pressure control and components of the metabolic syndrome: the GOOD survey

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy: the role of heart rate

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients With Preserved Left Ventricular Function

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Arterial baroreceptor and cardiopulmonary reflex control of sympathetic outflow in human heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Increased pulse wave velocity and not reduced ejection fraction is associated with impaired baroreflex control of heart rate in congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Prognostic value of the metabolic syndrome in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Metabolic syndrome and target organ damage in untreated essential hypertensives.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Influence of metabolic syndrome on hypertension-related target organ damage

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021

Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2012.61

7 January 2021